Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Study Summary

Previous related pageVitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence ReviewNext related pageVitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Full Evidence Review
Study at a glance

What did long-term studies examine about vitamin D, inflammation and ageing?

This page compares three long-term studies with different aims, called VITAL, DO-HEALTH and TILDA. VITAL measured blood signs of inflammation after vitamin D or placebo. DO-HEALTH tested vitamin D, omega-3 and exercise using estimates of how the body was ageing, based on DNA. TILDA observed whether starting vitamin D levels were linked with later categories of blood-sugar levels.

Did supplements change inflammation or estimates of ageing?

In VITAL, one inflammation marker was lower with vitamin D at two years, but not at four years. Other measured inflammatory substances showed no consistent benefit. In DO-HEALTH, vitamin D alone did not clearly change the four ageing estimates. Positive results involving omega-3 or combined treatments cannot be credited to vitamin D alone.

Were vitamin D levels linked with later blood-sugar problems?

In TILDA, lower starting vitamin D levels were linked with later prediabetes, meaning raised blood sugar below the diabetes range. The link with new diabetes cases was uncertain. Because researchers did not randomly assign vitamin D levels, other differences between participants could explain some of the association. One starting measurement also cannot show vitamin D levels throughout the time people were followed.

Do the studies show that vitamin D slows ageing or prevents disease?

The studies did not demonstrate a sequence in which vitamin D reduces inflammation, slows ageing of the immune system and prevents diabetes. Blood markers and DNA-based ageing estimates do not directly establish a better-working immune system or longer life. Fewer later samples, selected parts of the study groups and measurement limits add uncertainty. These studies do not establish an anti-ageing treatment or a supplement plan to prevent metabolic disease, which affects how the body processes nutrients.

Read the full article below ↓

Three long-term studies examined different outcomes: inflammatory blood markers, DNA-methylation estimates of ageing and later glycaemic status. Together they do not establish that vitamin D reduces chronic inflammation, rejuvenates immunity and prevents metabolic disease. Their value lies in showing which parts of that proposed sequence have evidence and which links remain unproven. Read the companion Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review.

Inflammatory markers: VITAL

Dong and colleagues analysed inflammatory markers in a VITAL subgroup assigned vitamin D or placebo. The sample included 1,054 participants at baseline, with fewer available at later visits. Most were not below the reported vitamin D deficiency threshold.

High-sensitivity C-reactive protein was lower with vitamin D at two years, but the finding was absent at four years. IL-6, IL-10 and TNF-α measurements did not show a consistent beneficial pattern. Some IL-6 values were outside the quantifiable assay range, limiting interpretation.

This is evidence about selected measurements relevant to Vitamin D and Chronic Inflammation, not proof of sustained suppression of every inflammatory process. It does not demonstrate that a marker difference caused a clinical benefit.

Biological-age estimates: DO-HEALTH

The DO-HEALTH analysis examined 777 older Swiss participants in a factorial trial of vitamin D, omega-3 and exercise. Vitamin D alone did not clearly change the four DNA-methylation clock measures considered. Some omega-3 and combination findings were positive, but a combined intervention result cannot be attributed independently to vitamin D.

These clocks are research estimates, not direct measurements of lifespan or immune competence. The study therefore does not establish improved immune function with ageing, the broader topic discussed in Vitamin D and Immune Ageing. Its post hoc subset design and endpoint multiplicity also require caution.

Metabolic outcomes: TILDA

McCarthy and colleagues related baseline vitamin D concentrations to later glycaemic status in an observational cohort. Lower vitamin D categories were associated with incident prediabetes over four years compared with the highest reference category. The incident-diabetes association was not clear and had substantial uncertainty.

Participants were not randomly assigned their vitamin D status. Residual confounding, a single baseline measurement and selection at follow-up limit causal interpretation. The study concerns later glycaemic classification; it did not directly demonstrate altered insulin signalling, the cellular process discussed in Vitamin D and Insulin Signalling.

Why the findings cannot be joined into a causal chain

The studies did not show that low vitamin D caused inflammation that then caused immune ageing or diabetes. In particular, the TILDA association was not demonstrated to be mediated by inflammation. A temporary hs-CRP difference in a separate trial cannot supply that missing mechanism.

The studies also measured different populations and outcomes. Epigenetic clocks, circulating proteins and HbA1c-based glycaemic categories are not interchangeable measures of one biological process. Vitamin D, Ageing, and Real-World Context provides wider context for interpreting ageing-related research without treating every surrogate as a real-world functional benefit.

The VITAL markers do not identify a specific mechanism among the pathways discussed in Vitamin D and Inflammatory Signalling. Nor do they prove correction of excessive immune activation, as discussed in Vitamin D and Immune Overactivation. Likewise, these analyses did not establish oxidative stress as the mediator between vitamin D status and metabolic outcomes; Vitamin D and Oxidative Stress explains that related physiological topic. These questions remain distinct from the measurements actually made.

Conclusion

The evidence supports a time-limited inflammatory-marker finding, no clear independent vitamin D effect on the selected ageing clocks, and an observational association with prediabetes. It does not establish an anti-ageing or metabolic-prevention regimen, and the research doses are not personal treatment recommendations.

This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.

Primary source and publication details

Related reading

Original sources

Source

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial

Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.

Publication details

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Yanbin Dong, Haidong Zhu, Li Chen, Ying Huang, William Christen, Nancy R Cook, Trisha Copeland, Samia Mora, Julie E Buring, I-Min Lee, Karen H Costenbader, JoAnn E Manson. Nutrients; 2022; 14; 24; 5307. DOI: 10.3390/nu14245307. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

Publication details

Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Heike A. Bischoff-Ferrari, Stephanie Gängler, Maud Wieczorek, Daniel W. Belsky, Joanne Ryan, Reto W. Kressig, Hannes B. Stähelin, Robert Theiler, Bess Dawson-Hughes, René Rizzoli, Bruno Vellas, Laure Rouch, Sophie Guyonnet, Andreas Egli, E. John Orav, Walter Willett, Steve Horvath. Nature Aging; 2025; 5; 3; 376 to 385. DOI: 10.1038/s43587-024-00793-y. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →
Source

Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA)

Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA).

Publication details

Association between vitamin D deficiency and the risk of prevalent type 2 diabetes and incident prediabetes: A prospective cohort study using data from The Irish Longitudinal Study on Ageing (TILDA). Kevin McCarthy, Eamon Laird, Aisling M O’Halloran, Cathal Walsh, Martin Healy, Annette L Fitzpatrick, James B Walsh, Belinda Hernández, Padraic Fallon, Anne M Molloy, Rose Anne Kenny. eClinicalMedicine; 2022; 53; 101654. DOI: 10.1016/j.eclinm.2022.101654. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.

Read more →